Global Specific Antiviral Drugs for COVID-19 Market Growth (Status and Outlook) 2023-2029

February 2023 | 101 pages | ID: GA878C2CA6FFEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

According to this study, the global Specific Antiviral Drugs for COVID-19 market size will reach US$ million by 2029.

This report presents a comprehensive overview, market shares, and growth opportunities of Specific Antiviral Drugs for COVID-19 market by product type, application, key players and key regions and countries.

Segmentation by product type:

• Tablet
• Injection

Segmentation by Application:

• Mild Symptom Patient
• Critically Ill Patient

This report also splits the market by region:

• United States
• China
• Europe
• Other regions:
• Japan
• South Korea
• Southeast Asia
• Rest of world

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• Sanofi
• Novartis
• Shanghai Zhongxisanwei
• Teva
• Zydus Cadila
• Mylan
• Apotex
• Advanz Pharma
• Sun Pharma
• Kyung Poong
• Ipca Laboratories
• Hanlim Pharmaceutical
• Bristol Laboratories
• Bayer
• Rising Pharmaceutical
• Shanghai Pharma
• Sichuan Sunny Hope
• Guangzhou Baiyunshan Guanghua Pharmaceutical
• CSPC Group
• KPC Group
• Jinghua Pharmaceutical Group
• Zhongsheng Pharma
• North China Pharmaceutical Group

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Specific Antiviral Drugs for COVID-19 Market Size 2024-2029
  2.1.2 Specific Antiviral Drugs for COVID-19 Market Size CAGR by Region
2.2 Specific Antiviral Drugs for COVID-19 Segment by Type
  2.2.1 Tablet
  2.2.2 Injection
2.3 Specific Antiviral Drugs for COVID-19 Market Size by Type
  2.3.1 Global Specific Antiviral Drugs for COVID-19 Market Size Market Share by Type (2024-2029)
  2.3.2 Global Specific Antiviral Drugs for COVID-19 Market Size Growth Rate by Type (2024-2029)
2.4 Specific Antiviral Drugs for COVID-19 Segment by Application
  2.4.1 Mild Symptom Patient
  2.4.2 Critically Ill Patient
2.5 Specific Antiviral Drugs for COVID-19 Market Size by Application
  2.5.1 Global Specific Antiviral Drugs for COVID-19 Market Size Market Share by Application (2024-2029)
  2.5.2 Global Specific Antiviral Drugs for COVID-19 Market Size Growth Rate by Application (2024-2029)

3 SPECIFIC ANTIVIRAL DRUGS FOR COVID-19 KEY PLAYERS

3.1 Date of Key Players Enter into Specific Antiviral Drugs for COVID-19
3.2 Key Players Specific Antiviral Drugs for COVID-19 Product Offered
3.3 Key Players Specific Antiviral Drugs for COVID-19 Funding/Investment Analysis
3.4 Funding/Investment
  3.4.1 Funding/Investment by Regions
  3.4.2 Funding/Investment by End-Industry
3.5 Key Players Specific Antiviral Drugs for COVID-19 Valuation & Market Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 Market Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions

4 SPECIFIC ANTIVIRAL DRUGS FOR COVID-19 BY REGIONS

4.1 Specific Antiviral Drugs for COVID-19 Market Size by Regions (2024-2029)
4.2 United States Specific Antiviral Drugs for COVID-19 Market Size Growth (2024-2029)
4.3 China Specific Antiviral Drugs for COVID-19 Market Size Growth (2024-2029)
4.4 Europe Specific Antiviral Drugs for COVID-19 Market Size Growth (2024-2029)
4.5 Rest of World Specific Antiviral Drugs for COVID-19 Market Size Growth (2024-2029)

5 UNITED STATES

5.1 United States Specific Antiviral Drugs for COVID-19 Market Size by Type (2024-2029)
5.2 United States Specific Antiviral Drugs for COVID-19 Market Size by Application (2024-2029)

6 EUROPE

6.1 Europe Specific Antiviral Drugs for COVID-19 Market Size by Type (2024-2029)
6.2 Europe Specific Antiviral Drugs for COVID-19 Market Size by Application (2024-2029)

7 CHINA

7.1 China Specific Antiviral Drugs for COVID-19 Market Size by Type (2024-2029)
7.2 China Specific Antiviral Drugs for COVID-19 Market Size by Application (2024-2029)

8 REST OF WORLD

8.1 Rest of World Specific Antiviral Drugs for COVID-19 Market Size by Type (2024-2029)
8.2 Rest of World Specific Antiviral Drugs for COVID-19 Market Size by Application (2024-2029)
8.3 Japan
8.4 South Korea
8.5 Southeast Asia

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 KEY INVESTORS IN SPECIFIC ANTIVIRAL DRUGS FOR COVID-19

10.1 Company A
  10.1.1 Company A Company Details
  10.1.2 Company Description
  10.1.3 Companies Invested by Company A
  10.1.4 Company A Key Development and Market Layout
10.2 Company B
  10.2.1 Company B Company Details
  10.2.2 Company Description
  10.2.3 Companies Invested by Company B
  10.2.4 Company B Key Development and Market Layout
10.3 Company C
  10.3.1 Company C Company Details
  10.3.2 Company Description
  10.3.3 Companies Invested by Company C
  10.3.4 Company C Key Development and Market Layout
10.4 Company D
10.5 ……

11 KEY PLAYERS ANALYSIS

11.1 Sanofi
  11.1.1 Sanofi Company Details
  11.1.2 Sanofi Specific Antiviral Drugs for COVID-19 Product Offered
  11.1.3 Sanofi Specific Antiviral Drugs for COVID-19 Market Size (2023 VS 2029)
  11.1.4 Sanofi Main Business Overview
  11.1.5 Sanofi News
11.2 Novartis
  11.2.1 Novartis Company Details
  11.2.2 Novartis Specific Antiviral Drugs for COVID-19 Product Offered
  11.2.3 Novartis Specific Antiviral Drugs for COVID-19 Market Size (2023 VS 2029)
  11.2.4 Novartis Main Business Overview
  11.2.5 Novartis News
11.3 Shanghai Zhongxisanwei
  11.3.1 Shanghai Zhongxisanwei Company Details
  11.3.2 Shanghai Zhongxisanwei Specific Antiviral Drugs for COVID-19 Product Offered
  11.3.3 Shanghai Zhongxisanwei Specific Antiviral Drugs for COVID-19 Market Size (2023 VS 2029)
  11.3.4 Shanghai Zhongxisanwei Main Business Overview
  11.3.5 Shanghai Zhongxisanwei News
11.4 Teva
  11.4.1 Teva Company Details
  11.4.2 Teva Specific Antiviral Drugs for COVID-19 Product Offered
  11.4.3 Teva Specific Antiviral Drugs for COVID-19 Market Size (2023 VS 2029)
  11.4.4 Teva Main Business Overview
  11.4.5 Teva News
11.5 Zydus Cadila
  11.5.1 Zydus Cadila Company Details
  11.5.2 Zydus Cadila Specific Antiviral Drugs for COVID-19 Product Offered
  11.5.3 Zydus Cadila Specific Antiviral Drugs for COVID-19 Market Size (2023 VS 2029)
  11.5.4 Zydus Cadila Main Business Overview
  11.5.5 Zydus Cadila News
11.6 Mylan
  11.6.1 Mylan Company Details
  11.6.2 Mylan Specific Antiviral Drugs for COVID-19 Product Offered
  11.6.3 Mylan Specific Antiviral Drugs for COVID-19 Market Size (2023 VS 2029)
  11.6.4 Mylan Main Business Overview
  11.6.5 Mylan News
11.7 Apotex
  11.7.1 Apotex Company Details
  11.7.2 Apotex Specific Antiviral Drugs for COVID-19 Product Offered
  11.7.3 Apotex Specific Antiviral Drugs for COVID-19 Market Size (2023 VS 2029)
  11.7.4 Apotex Main Business Overview
  11.7.5 Apotex News
11.8 Advanz Pharma
  11.8.1 Advanz Pharma Company Details
  11.8.2 Advanz Pharma Specific Antiviral Drugs for COVID-19 Product Offered
  11.8.3 Advanz Pharma Specific Antiviral Drugs for COVID-19 Market Size (2023 VS 2029)
  11.8.4 Advanz Pharma Main Business Overview
  11.8.5 Advanz Pharma News
11.9 Sun Pharma
  11.9.1 Sun Pharma Company Details
  11.9.2 Sun Pharma Specific Antiviral Drugs for COVID-19 Product Offered
  11.9.3 Sun Pharma Specific Antiviral Drugs for COVID-19 Market Size (2023 VS 2029)
  11.9.4 Sun Pharma Main Business Overview
  11.9.5 Sun Pharma News
11.10 Kyung Poong
  11.10.1 Kyung Poong Company Details
  11.10.2 Kyung Poong Specific Antiviral Drugs for COVID-19 Product Offered
  11.10.3 Kyung Poong Specific Antiviral Drugs for COVID-19 Market Size (2023 VS 2029)
  11.10.4 Kyung Poong Main Business Overview
  11.10.5 Kyung Poong News
11.11 Ipca Laboratories
11.12 Hanlim Pharmaceutical
11.13 Bristol Laboratories
11.14 Bayer
11.15 Rising Pharmaceutical
11.16 Shanghai Pharma
11.17 Sichuan Sunny Hope
11.18 Guangzhou Baiyunshan Guanghua Pharmaceutical
11.19 CSPC Group
11.20 KPC Group
11.21 Jinghua Pharmaceutical Group
11.22 Zhongsheng Pharma
11.23 North China Pharmaceutical Group

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Specific Antiviral Drugs for COVID-19 Market Size CAGR by Region (2024-2029) ($ Millions)
Table 2. Major Players of Tablet
Table 3. Major Players of Injection
Table 4. Global Specific Antiviral Drugs for COVID-19 Market Size by Type (2024-2029) ($ Millions)
Table 5. Global Specific Antiviral Drugs for COVID-19 Market Size Market Share by Type (2024-2029)
Table 6. Global Specific Antiviral Drugs for COVID-19 Market Size by Application (2024-2029) ($ Millions)
Table 7. Global Specific Antiviral Drugs for COVID-19 Market Size Market Share by Application (2024-2029)
Table 8. Date of Global Key Players Enter into Specific Antiviral Drugs for COVID-19 Market
Table 9. Global Key Players Specific Antiviral Drugs for COVID-19 Product Offered
Table 10. Key Players Specific Antiviral Drugs for COVID-19 Funding/Investment ($ Millions)
Table 11. Funding/Investment by Regions
Table 12. Funding/Investment by End Industry
Table 13. Key Players Specific Antiviral Drugs for COVID-19 Valuation & Market Capitalization ($ Millions)
Table 14. Key Players Mergers & Acquisitions, Expansion Plans
Table 15. Specific Antiviral Drugs for COVID-19 New Product/Technology Launches
Table 16. Specific Antiviral Drugs for COVID-19 Industry Partnerships, Agreements, and Collaborations
Table 17. Specific Antiviral Drugs for COVID-19 Industry Mergers and Acquisitions
Table 18. Global Specific Antiviral Drugs for COVID-19 Market Size by Regions 2024-2029 ($ Millions)
Table 19. Global Specific Antiviral Drugs for COVID-19 Market Size Market Share by Regions 2024-2029
Table 20. United States Specific Antiviral Drugs for COVID-19 Market Size by Type (2024-2029) ($ Millions)
Table 21. United States Specific Antiviral Drugs for COVID-19 Market Size Market Share by Type (2024-2029)
Table 22. United States Specific Antiviral Drugs for COVID-19 Market Size by Application (2024-2029) ($ Millions)
Table 23. United States Specific Antiviral Drugs for COVID-19 Market Size Market Share by Application (2024-2029)
Table 24. Europe Specific Antiviral Drugs for COVID-19 Market Size by Type (2024-2029) ($ Millions)
Table 25. Europe Specific Antiviral Drugs for COVID-19 Market Size Market Share by Type (2024-2029)
Table 26. Europe Specific Antiviral Drugs for COVID-19 Market Size by Application (2024-2029) ($ Millions)
Table 27. Europe Specific Antiviral Drugs for COVID-19 Market Size Market Share by Application (2024-2029)
Table 28. China Specific Antiviral Drugs for COVID-19 Market Size by Type (2024-2029) ($ Millions)
Table 29. China Specific Antiviral Drugs for COVID-19 Market Size Market Share by Type (2024-2029)
Table 30. China Specific Antiviral Drugs for COVID-19 Market Size by Application (2024-2029) ($ Millions)
Table 31. China Specific Antiviral Drugs for COVID-19 Market Size Market Share by Application (2024-2029)
Table 32. Rest of World Specific Antiviral Drugs for COVID-19 Market Size by Type (2024-2029) ($ Millions)
Table 33. Rest of World Specific Antiviral Drugs for COVID-19 Market Size Market Share by Type (2024-2029)
Table 34. Rest of World Specific Antiviral Drugs for COVID-19 Market Size by Application (2024-2029) ($ Millions)
Table 35. Rest of World Specific Antiviral Drugs for COVID-19 Market Size Market Share by Application (2024-2029)
Table 36. Key Market Drivers & Growth Opportunities of Specific Antiviral Drugs for COVID-19
Table 37. Key Market Challenges & Risks of Specific Antiviral Drugs for COVID-19
Table 38. Key Industry Trends of Specific Antiviral Drugs for COVID-19
Table 39. Company A Company Details
Table 40. Companies Invested by Company A
Table 41. Company A Key Development and Market Layout
Table 42. Company B Company Details
Table 43. Companies Invested by Company B
Table 44. Company B Key Development and Market Layout
Table 45. Company C Company Details
Table 46. Companies Invested by Company C
Table 47. Company C Key Development and Market Layout
Table 48. Company C Company Details
Table 49. Companies Invested by Company C
Table 50. Company C Key Development and Market Layout
Table 51. Sanofi Basic Information, Head Office, Major Market Areas and Its Competitors
Table 52. Sanofi Specific Antiviral Drugs for COVID-19 Market Size (2023 VS 2029)
Table 53. Novartis Basic Information, Head Office, Major Market Areas and Its Competitors
Table 54. Novartis Specific Antiviral Drugs for COVID-19 Market Size (2023 VS 2029)
Table 55. Shanghai Zhongxisanwei Basic Information, Head Office, Major Market Areas and Its Competitors
Table 56. Shanghai Zhongxisanwei Specific Antiviral Drugs for COVID-19 Market Size (2023 VS 2029)
Table 57. Teva Basic Information, Head Office, Major Market Areas and Its Competitors
Table 58. Teva Specific Antiviral Drugs for COVID-19 Market Size (2023 VS 2029)
Table 59. Zydus Cadila Basic Information, Head Office, Major Market Areas and Its Competitors
Table 60. Zydus Cadila Specific Antiviral Drugs for COVID-19 Market Size (2023 VS 2029)
Table 61. Mylan Basic Information, Head Office, Major Market Areas and Its Competitors
Table 62. Mylan Specific Antiviral Drugs for COVID-19 Market Size (2023 VS 2029)
Table 63. Apotex Basic Information, Head Office, Major Market Areas and Its Competitors
Table 64. Apotex Specific Antiviral Drugs for COVID-19 Market Size (2023 VS 2029)
Table 65. Advanz Pharma Basic Information, Head Office, Major Market Areas and Its Competitors
Table 66. Advanz Pharma Specific Antiviral Drugs for COVID-19 Market Size (2023 VS 2029)
Table 67. Sun Pharma Basic Information, Head Office, Major Market Areas and Its Competitors
Table 68. Sun Pharma Specific Antiviral Drugs for COVID-19 Market Size (2023 VS 2029)
Table 69. Kyung Poong Basic Information, Head Office, Major Market Areas and Its Competitors
Table 70. Kyung Poong Specific Antiviral Drugs for COVID-19 Market Size (2023 VS 2029)
Table 71. Ipca Laboratories Basic Information, Head Office, Major Market Areas and Its Competitors
Table 72. Ipca Laboratories Specific Antiviral Drugs for COVID-19 Market Size (2023 VS 2029)
Table 73. Hanlim Pharmaceutical Basic Information, Head Office, Major Market Areas and Its Competitors
Table 74. Hanlim Pharmaceutical Specific Antiviral Drugs for COVID-19 Market Size (2023 VS 2029)
Table 75. Bristol Laboratories Basic Information, Head Office, Major Market Areas and Its Competitors
Table 76. Bristol Laboratories Specific Antiviral Drugs for COVID-19 Market Size (2023 VS 2029)
Table 77. Bayer Basic Information, Head Office, Major Market Areas and Its Competitors
Table 78. Bayer Specific Antiviral Drugs for COVID-19 Market Size (2023 VS 2029)
Table 79. Rising Pharmaceutical Basic Information, Head Office, Major Market Areas and Its Competitors
Table 80. Rising Pharmaceutical Specific Antiviral Drugs for COVID-19 Market Size (2023 VS 2029)
Table 81. Shanghai Pharma Basic Information, Head Office, Major Market Areas and Its Competitors
Table 82. Shanghai Pharma Specific Antiviral Drugs for COVID-19 Market Size (2023 VS 2029)
Table 83. Sichuan Sunny Hope Basic Information, Head Office, Major Market Areas and Its Competitors
Table 84. Sichuan Sunny Hope Specific Antiviral Drugs for COVID-19 Market Size (2023 VS 2029)
Table 85. Guangzhou Baiyunshan Guanghua Pharmaceutical Basic Information, Head Office, Major Market Areas and Its Competitors
Table 86. Guangzhou Baiyunshan Guanghua Pharmaceutical Specific Antiviral Drugs for COVID-19 Market Size (2023 VS 2029)
Table 87. CSPC Group Basic Information, Head Office, Major Market Areas and Its Competitors
Table 88. CSPC Group Specific Antiviral Drugs for COVID-19 Market Size (2023 VS 2029)
Table 89. KPC Group Basic Information, Head Office, Major Market Areas and Its Competitors
Table 90. KPC Group Specific Antiviral Drugs for COVID-19 Market Size (2023 VS 2029)
Table 91. Jinghua Pharmaceutical Group Basic Information, Head Office, Major Market Areas and Its Competitors
Table 92. Jinghua Pharmaceutical Group Specific Antiviral Drugs for COVID-19 Market Size (2023 VS 2029)
Table 93. Zhongsheng Pharma Basic Information, Head Office, Major Market Areas and Its Competitors
Table 94. Zhongsheng Pharma Specific Antiviral Drugs for COVID-19 Market Size (2023 VS 2029)
Table 95. North China Pharmaceutical Group Basic Information, Head Office, Major Market Areas and Its Competitors
Table 96. North China Pharmaceutical Group Specific Antiviral Drugs for COVID-19 Market Size (2023 VS 2029)

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Specific Antiviral Drugs for COVID-19
Figure 2. Specific Antiviral Drugs for COVID-19 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Specific Antiviral Drugs for COVID-19 Market Size Growth Rate 2024-2029 ($ Millions)
Figure 7. Specific Antiviral Drugs for COVID-19 Market Size by Region (2023 & 2029) ($ millions)
Figure 8. Global Specific Antiviral Drugs for COVID-19 Market Size Market Share by Type (2024-2029)
Figure 9. Global Tablet Market Size Growth Rate
Figure 10. Global Injection Market Size Growth Rate
Figure 11. Specific Antiviral Drugs for COVID-19 in Mild Symptom Patient
Figure 12. Global Specific Antiviral Drugs for COVID-19 Market: Mild Symptom Patient (2024-2029) ($ Millions)
Figure 13. Specific Antiviral Drugs for COVID-19 in Critically Ill Patient
Figure 14. Global Specific Antiviral Drugs for COVID-19 Market: Critically Ill Patient (2024-2029) ($ Millions)
Figure 15. Global Specific Antiviral Drugs for COVID-19 Market Size Market Share by Application (2024-2029)
Figure 16. Global Specific Antiviral Drugs for COVID-19 Market Size in Mild Symptom Patient Growth Rate
Figure 17. Global Specific Antiviral Drugs for COVID-19 Market Size in Critically Ill Patient Growth Rate
Figure 18. Funding/Investment
Figure 19. Global Specific Antiviral Drugs for COVID-19 Market Size Market Share by Regions 2024-2029
Figure 20. United States Specific Antiviral Drugs for COVID-19 Market Size 2024-2029 ($ Millions)
Figure 21. China Specific Antiviral Drugs for COVID-19 Market Size 2024-2029 ($ Millions)
Figure 22. Europe Specific Antiviral Drugs for COVID-19 Market Size 2024-2029 ($ Millions)
Figure 23. Rest of World Specific Antiviral Drugs for COVID-19 Market Size 2024-2029 ($ Millions)
Figure 24. United States Specific Antiviral Drugs for COVID-19 Consumption Market Share by Type in 2029
Figure 25. United States Specific Antiviral Drugs for COVID-19 Market Size Market Share by Application in 2029
Figure 26. China Specific Antiviral Drugs for COVID-19 Consumption Market Share by Type in 2029
Figure 27. China Specific Antiviral Drugs for COVID-19 Market Size Market Share by Application in 2029
Figure 28. Europe Specific Antiviral Drugs for COVID-19 Consumption Market Share by Type in 2029
Figure 29. Europe Specific Antiviral Drugs for COVID-19 Market Size Market Share by Application in 2029
Figure 30. Rest of World Specific Antiviral Drugs for COVID-19 Consumption Market Share by Type in 2029
Figure 31. Rest of World Specific Antiviral Drugs for COVID-19 Market Size Market Share by Application in 2029